Evidence map›Paper›PMID 39658112›Full record

ArticleSaudi medical journal2024

Prevalence of hyperlipidemia in psoriatic arthritis patients in Riyadh, Saudi Arabia.

Khalid AlTalhi, Sara Alotaiwi, Mohammed Alotaibi, Hanan A Alhamzi, Seham Alrashedi, Mosaab Makkawy, Fahdah Alokaily

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Saudi medical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Khalid AlTalhiFrom the Internal Medicine and Rheumatology Department (AlTalhi), King Abdulaziz Specialist Hospital, Taif; from the Rheumatology Department, Prince Mohammed bin Abdulaziz Hospital (Otaywi, Alhamzi, Makkawy); from the Internal Medicine And Rheumatology Department (Alrashedi, Alokaily), Prince Sultan Military Medical City, Riyadh; from the Internal Medicine (Alotaibi), Shaqra University, Shaqra, Kingdom of Saudi Arabia.
Sara AlotaiwiFrom the Internal Medicine and Rheumatology Department (AlTalhi), King Abdulaziz Specialist Hospital, Taif; from the Rheumatology Department, Prince Mohammed bin Abdulaziz Hospital (Otaywi, Alhamzi, Makkawy); from the Internal Medicine And Rheumatology Department (Alrashedi, Alokaily), Prince Sultan Military Medical City, Riyadh; from the Internal Medicine (Alotaibi), Shaqra University, Shaqra, Kingdom of Saudi Arabia.
Mohammed AlotaibiFrom the Internal Medicine and Rheumatology Department (AlTalhi), King Abdulaziz Specialist Hospital, Taif; from the Rheumatology Department, Prince Mohammed bin Abdulaziz Hospital (Otaywi, Alhamzi, Makkawy); from the Internal Medicine And Rheumatology Department (Alrashedi, Alokaily), Prince Sultan Military Medical City, Riyadh; from the Internal Medicine (Alotaibi), Shaqra University, Shaqra, Kingdom of Saudi Arabia.
Hanan A AlhamziFrom the Internal Medicine and Rheumatology Department (AlTalhi), King Abdulaziz Specialist Hospital, Taif; from the Rheumatology Department, Prince Mohammed bin Abdulaziz Hospital (Otaywi, Alhamzi, Makkawy); from the Internal Medicine And Rheumatology Department (Alrashedi, Alokaily), Prince Sultan Military Medical City, Riyadh; from the Internal Medicine (Alotaibi), Shaqra University, Shaqra, Kingdom of Saudi Arabia.
Seham AlrashediFrom the Internal Medicine and Rheumatology Department (AlTalhi), King Abdulaziz Specialist Hospital, Taif; from the Rheumatology Department, Prince Mohammed bin Abdulaziz Hospital (Otaywi, Alhamzi, Makkawy); from the Internal Medicine And Rheumatology Department (Alrashedi, Alokaily), Prince Sultan Military Medical City, Riyadh; from the Internal Medicine (Alotaibi), Shaqra University, Shaqra, Kingdom of Saudi Arabia.
Mosaab MakkawyFrom the Internal Medicine and Rheumatology Department (AlTalhi), King Abdulaziz Specialist Hospital, Taif; from the Rheumatology Department, Prince Mohammed bin Abdulaziz Hospital (Otaywi, Alhamzi, Makkawy); from the Internal Medicine And Rheumatology Department (Alrashedi, Alokaily), Prince Sultan Military Medical City, Riyadh; from the Internal Medicine (Alotaibi), Shaqra University, Shaqra, Kingdom of Saudi Arabia.
Fahdah AlokailyFrom the Internal Medicine and Rheumatology Department (AlTalhi), King Abdulaziz Specialist Hospital, Taif; from the Rheumatology Department, Prince Mohammed bin Abdulaziz Hospital (Otaywi, Alhamzi, Makkawy); from the Internal Medicine And Rheumatology Department (Alrashedi, Alokaily), Prince Sultan Military Medical City, Riyadh; from the Internal Medicine (Alotaibi), Shaqra University, Shaqra, Kingdom of Saudi Arabia.ORCID https://orcid.org/0000-0003-0878-0200

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo estimate the prevalence of hyperlipidemia in patients with psoriatic arthritis (PsA) in Riyadh, Saudi Arabia, and to investigate the relationship between PsA and hyperlipidemia.

methodsThis retrospective study examined medical records of PsA patients from January 2010 to May 2023 at 2 medical centers in Riyadh. Patients over 18 years old with a lipid profile were included. Hyperlipidemia cases were determined using Adult Treatment Panel III (ATP III) guidelines and European Association of Preventive Cardiology definitions based on lipid profile results.

resultsA total of 141 patients were included in the analysis. The prevalence of hyperlipidemia in patients with PsA was 40.7% at diagnosis, and 28.7% at the last visit. The prevalence of hyperlipidemia was significantly higher in males than females (56% versus [vs] 29.4%,

conclusionThe study results are comparable to those of other studies showing no significant effect of PsA on the lipid profile. The prevalence of hyperlipidemia in PsA patients appears similar to that of the general population in Saudi Arabia, based on indirect comparison.

Indexed as

Arthritis, PsoriaticHyperlipidemiasAdultAntirheumatic AgentsFemaleHumansMaleMiddle AgedPrevalenceRetrospective StudiesSaudi ArabiaAntirheumatic Agentslipid profilemedical recordsprevalenceretrospective studyRiyadhSaudi Arabia

Identifiers

PMID39658112
PMCPMC11629641

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.